Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Transplantation in Alcoholic Liver Cirrhosis (Randomized Exploratory Phase 2 Trial)
KCT0000775Phase 2Recruiting
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Jun 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cell therapy (Hexun Biosciences) in Cirrhosis, sponsored by Pharmicell Co., Ltd.. Started Jun 2013; status: recruiting.
02
Drugs
mesenchymal stem cell therapy (Hexun Biosciences)
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on KCT0000775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000775.